ADCT
ADC Therapeutics S.A.
NYSE · CHHealthcareBiotechnology
$1.26-6.67%
Price as of Jul 20, 2026
ADCT capital
ADC Therapeutics S.A. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- -0.54x
- Net debt / equity
- 0.53x
- Debt / assets
- 0.40x
- Debt / EBITDA
- -1.40x
- Net debt / EBITDA
- 1.37x
Liquidity & coverage
- Current ratio
- 4.09x
- Quick ratio
- 4.02x
- Cash ratio
- 3.42x
- Interest coverage
- -2.28x
- EBITDA / interest
- -1.61x
- Working capital
- $209.1M
Cash & dividend
- FCF / debt
- -0.98x
- Cash flow / debt
- -0.98x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.